bcl-2 expression and the development of endometrial carcinoma

Modern Pathology

Volumn 9, Issue 4, 1996, Pages 402-406

  Chhieng, David C ^a   Ross, Jeffrey S ^a   Ambros, Robert A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Apoptosis; bcl 2 gene; Endometrial carcinoma

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS;

EID: 0029972637     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tsujimoto Y, Groham J, Cossman J, Jaffe E, Croce CM: The t(14,18) chromosome translocations involved in B-cell neoplasms result mistakes in VDJ joining. Science 229:1390, 1985
2. Cleary ML, Sklar J: Nucleotide sequence of a t(14,18) chromosomal breakpoint in follicular and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A 82:7439, 1985
3. Bakhshi A, Jensen JP, Goldman P, et al.: Cloning the chromosomal breakpoint of t(14,18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit of 18. Cell 41:899, 1985
4. Chen-Leavy Z, Nourse J, Cleary ML: The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14,18) translocation. Mol Cell Biol 9:701, 1989
5. Cleary ML, Smith SD, Sklar J: Cloning and structure analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14,18) translocation. Cell 47:19, 1986
6. Graninger WB, Seto M, Boutain B, Goldman P, Korsmeyer SJ: Expression of bcl-2 and bcl-2 fusion transcripts in normal and neoplastic cells. J Clin Invest 80:1512, 1987
7. Reed JC, Tsujimoto Y, Epstein SF, et al.: Regulation of bcl-2 gene expression in lymphoid cell lines containing normal #18 or t(14,18) chromosomes. Oncogene Res 4:271, 1989
8. McDonnell TJ, Deane N, Platt FM, et al.: bcl-2 immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell 57:79, 1989
9. Katsimata M, Siegel RM, Louie DC, et al.: Differential effects of bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci U S A 89:11376, 1992
10. Strasser A, Harris AW, Cory S: Eu-bcl-2 trangene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene 8:1, 1993
11. Hockenbery DM, Zutter M, Hickey W, Hahm M, Korsmeyer SJ: bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88:6961, 1991
12. Gompela A, Sabourin JC, Martin A, et al.: bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 144:1195, 1994
13. Ambros RA, Vigna PA, Figge J, et al.: Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53. Cancer 73:1686, 1994
14. FIGO: Corpus cancer staging. Int J Gynecol Obstet 28:190, 1989
15. Kurman RJ, Norris HJ: Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49:2547, 1982
16. Vojtesek B, Bartek J, Midgley CA, Lane DP: An immunochemical analysis of the human nuclear phosphoprotein p53. J Immunol Meth 151:237, 1992
17. Shi SR, Key ME, Karla KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochemi 39:741, 1991
18. Boyd JA, Kaufman DG: Expression of transforming growth factor in human endometrial carcinoma cell lines: Inverse correlation with effects on growth rate and morphology. Cancer Res 50:3394, 1990
19. Greene GL, Nolan C, Engler JP, Jensen EV: Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci U S A 77:5115, 1980
20. Perrot-Applanot M, Logeat F, Griyer-Picard MT, Milgrom E: Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies. Endocrinology 116:1473, 1985
21. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14,18). Nature 349:254, 1991
22. Hockenbery DM, Oltvai ZN, Tin XM, Milliman CL, Korsmeyer SL: bcl-2 functions in an antioxidant pathway to prevent Apoptosis. Cell 75:241, 1991
23. Hockenbery DM, Nunex G, Milliman CL, Schreiber RD, Korsmyer SL: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:344, 1991
24. Selvakurmaran M, Lin HK, Muyashita T, et al.: Immediate early up-regulation of bac expression by p53 but not TGFB1: A paradigm for distinct apoptotic pathways. Oncogen 9:1791, 1994
25. Miyashita T, Krajewski S, Krajewski M, et al.: Tumor supressor p53 is a regulator of bcl-2 and Bax gene expression in vitro and in vivo. Oncogene 9:1799, 1994
26. Gold LI, Saxena B, Mittal KR, et al.: Increased expression of transforming growth factor B isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: Evidence of paracrine and autocrine action. Cancer Res 54:2347, 1994
27. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095, 1994